Optimising first-line subtyping-based therapy in triple-negative breast cancer (FUTURE-SUPER): a multi-cohort, randomised, phase 2 trial

Lei Fan, Zhonghua Wang, Linxiaoxi Ma, Song‐Yang Wu, Jiong Wu, Ke‐Da Yu, Xin-Yi Sui, Ying Xu, Xiyu Liu, Li Chen, Wenjuan Zhang, Xi Jin, Qin Xiao, Ruohong Shui, Yi Xiao, Han Wang, Yun‐Song Yang, Xiaoyan Huang, A‐Yong Cao, Junjie Li, Gen‐Hong Di, Guang‐Yu Liu, Wen-Tao Yang, Xin Hu, Yan Xia, Qian-Nan Liang, Yi‐Zhou Jiang, Zhi‐Ming Shao